These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24292792)

  • 21. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.
    Kovats S; Turner S; Simmons A; Powe T; Chakravarty E; Alberola-Ila J
    Clin Exp Immunol; 2016 Nov; 186(2):214-226. PubMed ID: 27513522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.
    Rotolo A; Caputo VS; Holubova M; Baxan N; Dubois O; Chaudhry MS; Xiao X; Goudevenou K; Pitcher DS; Petevi K; Kachramanoglou C; Iles S; Naresh K; Maher J; Karadimitris A
    Cancer Cell; 2018 Oct; 34(4):596-610.e11. PubMed ID: 30300581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy.
    Kharkwal SS; Johndrow CT; Veerapen N; Kharkwal H; Saavedra-Avila NA; Carreño LJ; Rothberg S; Zhang J; Garforth SJ; Jervis PJ; Zhang L; Donda A; Besra AK; Cox LR; Almo SC; Howell A; Evans EE; Zauderer M; Besra GS; Porcelli SA
    Cancer Res; 2021 Apr; 81(7):1788-1801. PubMed ID: 33483371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD1d treatment suppresses immunogenic maturation of lung dendritic cells dependent on lung invariant natural killer T cells in asthmatic mice.
    Lin Q; Wang T; Zuo X; Ni H; Zhong J; Zhan L; Cheng H; Huang Y; Ding X; Yu H; Nie H
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110921. PubMed ID: 37725846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of invariant natural killer T cells for gastric cancer treatment.
    Xu Q; Li J; Zhang N; Zhang L; Qian R
    Future Oncol; 2018 Aug; 14(20):2053-2066. PubMed ID: 30051730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.
    Napolitano A; Pittoni P; Beaudoin L; Lehuen A; Voehringer D; MacDonald HR; Dellabona P; Casorati G
    J Immunol; 2013 Apr; 190(7):3299-308. PubMed ID: 23427253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
    J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
    Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
    Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.
    Tian C; Wang Y; Su M; Huang Y; Zhang Y; Dou J; Zhao C; Cai Y; Pan J; Bai S; Wu Q; Chen S; Li S; Xie D; Lv R; Chen Y; Wang Y; Fu S; Zhang H; Bai L
    Nat Commun; 2024 Feb; 15(1):1213. PubMed ID: 38332012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression.
    Ni C; Wu P; Wu X; Zhang T; Zhang T; Wang Z; Zhang S; Qiu F; Huang J
    Cancer Lett; 2015 Jan; 356(2 Pt B):579-88. PubMed ID: 25304368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autophagy machinery restrains iNKT cell activation through CD1D1 internalization.
    Keller CW; Loi M; Ewert S; Quast I; Theiler R; Gannagé M; Münz C; De Libero G; Freigang S; Lünemann JD
    Autophagy; 2017 Jun; 13(6):1025-1036. PubMed ID: 28296542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody.
    Patel NP; Guan P; Bahal D; Hashem T; Scheuplein F; Schaub R; Nichols KE; Das R
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CD4
    Baiu DC; Sharma A; Schehr JL; Basu J; Smith KA; Ohashi M; Johannsen EC; Kenney SC; Gumperz JE
    Immunology; 2024 Aug; 172(4):627-640. PubMed ID: 38736328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
    Yang JQ; Wen X; Kim PJ; Singh RR
    J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redirecting iNKT Cell Antitumor Immunity with α-GalCer/CD1d-scFv Fusion Proteins.
    Zhang L; Donda A
    Methods Mol Biol; 2021; 2388():175-180. PubMed ID: 34524672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel in vitro invariant natural killer T cell functional assays.
    Balasko A; Graydon C; Fowke KR
    J Immunol Methods; 2021 Dec; 499():113171. PubMed ID: 34706265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
    Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
    Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies.
    Melo AM; Conroy MJ; Foley EK; Dockry É; Breen EP; Reynolds JV; Lysaght J; Doherty DG
    Cancer Immunol Immunother; 2020 Jun; 69(6):969-982. PubMed ID: 32078695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features.
    Lameris R; de Bruin RC; van Bergen En Henegouwen PM; Verheul HM; Zweegman S; de Gruijl TD; van der Vliet HJ
    Immunology; 2016 Sep; 149(1):111-21. PubMed ID: 27312006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.